tiprankstipranks
Trending News
More News >
pc:cella

Cellares

Cellares is an Integrated Development and Manufacturing Organization (IDMO) focused on the automated, large-scale manufacture of cell therapies for biopharmaceutical partners. The company develops fully automated, cGMP-compliant manufacturing and quality-control platforms—Cell Shuttle™ for end-to-end production and Cell Q™ for in-process and release testing—and builds Smart Factory networks to increase throughput, consistency, and reduce per-patient costs.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$257M
Total Amount Raised$257M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$257M
Latest Funding Amount$257M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 28, 2026
Series D
$257.00M

Investors

Investor Name
Funding Round

Related News and Analysis